Are Monoclonal Antibodies the Answer to the Antibiotic Resistance Problem?
NOV 08, 2017 | CONTAGION® EDITORIAL STAFF
James S. Lewis, PharmD, FIDSA, co-director of antibiotic stewardship, Oregon Health and Science University, discusses the need for the development of non-antibacterial options against infections, such as monoclonal antibodies.
Interview Transcript (modified slightly for readability):
"One of the best things that I think we can do [to help the problem of antibiotic resistance] is consider non-antibacterial options as well, such as monoclonal antibodies, and immune modulators. [We need to be] thinking about alternative targets, and thinking about them differently than perhaps we have before because we know that every new antibiotic that we brought to market, [we will] rapidly see emergence in resistance to that antibiotic.
Thinking about alternative ways of doing things in infection models right now is really important. We’re going to keep hitting our head up against this resistance wall, and so, we need to be thinking about other things we can do to potentially get around that. Monoclonal antibodies, I think, again, are a very good example of that. There’s a lot of work and interest in phages right now as well.
I think we’re seeing some of the movement in these areas, kind of venturing out and exploring these other things, but we’ve kind of talked about monoclonal antibodies. [However,] any time you put “mab” at the end of something, it comes with a fairly healthy price tag. There’s this economic piece that kind of lurks out there as well that we can’t ignore, and we have to be willing to talk about how we incentivize the development of therapeutic agents in these areas.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Influenza A (H3N2) has caused most of the illnesses in this severe flu season, but influenza B is becoming increasingly responsible for more infections as the flu season continues to hit the United States.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512